Chemotherapy through lysosomes with a DNA-daunorubicin complex.
D000818:Animals; D002478:Cells, Cultured; D004247:DNA / Q000008:administration & dosage* / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D003630:Daunorubicin / Q000008:administration & dosage* / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D004338:Drug Combinations; D007275:Injections, Intravenous; D007942:Leukemia, Experimental / Q000188:drug therapy; D007951:Leukemia, Myeloid; D008247:Lysosomes / Q000378:metabolism*; D051379:Mice; D008811:Mice, Inbred DBA; D008815:Mice, Inbred Strains; D010873:Pinocytosis; D011485:Protein Binding; D012513:Sarcoma, Experimental; D013210:Staphylococcus / Q000187:drug effects
D004338:Drug Combinations; D004247:DNA; D003630:Daunorubicin